From the Old World to the New World: An ecologic study of population susceptibility to HIV infection

Tropical Medicine and International Health

Volumn 10, Issue 7, 2005, Pages 627-639

  Pepin, Jacques ^a,b  

^a UNIVERSITÉ DE SHERBROOKE   (Canada)

^b CENTRE HOSPITALIER UNIVERSITAIRE DE SHERBROOKE   (Canada)

Author keywords

Africa; Americas; Asia; Europe; Genetic susceptibility; HIV; Migration

Indexed keywords

DISEASE PREVALENCE; HUMAN IMMUNODEFICIENCY VIRUS;

ADOLESCENT; ADULT; AMERICAN INDIAN; ARTICLE; CONTROLLED STUDY; DISEASE PREDISPOSITION; ECOLOGY; ETHNIC DIFFERENCE; GEOGRAPHIC DISTRIBUTION; HOST SUSCEPTIBILITY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HUMAN IMMUNODEFICIENCY VIRUS PREVALENCE; MAJOR CLINICAL STUDY; POPULATION RESEARCH; RACE DIFFERENCE; SEXUAL BEHAVIOR; SEXUALLY TRANSMITTED DISEASE; VIRUS TRANSMISSION;

ADOLESCENT; ADULT; AFRICA; AMERICAS; EMIGRATION AND IMMIGRATION; EUROPE; GENETIC PREDISPOSITION TO DISEASE; HIV INFECTIONS; HUMANS; INDIANS, NORTH AMERICAN; MIDDLE AGED; PREVALENCE; SIBERIA;

HUMAN IMMUNODEFICIENCY VIRUS;

EID: 21644458272     PISSN: 13602276     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1365-3156.2005.01441.x     Document Type: Article

References (69)

1. Aidoo M, Terlouw D, Kolczak MS et al. (2002) Protective effects of the sickle cell gene against malaria morbidity and mortality. Lancet 359, 1311-1312.
2. AIDS Foundation East-West (2004) Officially registered HIV cases in the Russian Federation regions, 1987-2002. http://www. afew.org/English/.
3. Anzala AO, Ball TB, Rostron T et al. (1998) CCR2-64I allele and genotype association with delayed AIDS progression in African women. Lancet 351, 1632-1633.
4. Boersma JT, Ghys PD & Walker N (2003) Estimates of HIV-1 prevalence from national population-based surveys as a new gold standard. Lancet 362, 1929-1931.
5. Bortolini MC, Salzano FM, Thomas MG et al. (2003) Y-chromosome evidence for differing ancient demographic histories in the Americas. American Journal of Human Genetics 73, 524-539.
6. Buvé A, Carael M, Hayes RJ et al. (2001) The multicentre study on factors determining the differential spread of HIV in four African cities: summary and conclusions. AIDS 15 (Suppl. 4): S127-S131.
7. Buvé A, Bishikwabo-Nsarhaza K & Mutangadura G (2002) The spread and effect of HIV-1 infection in sub-Saharan Africa. Lancet 359, 2011-2017.
8. Centers for Disease Control and Prevention (2001a) HIV incidence among young men who have sex with men-seven US cities, 1994-2000. Morbidity and Mortality Weekly Report 50, 440-444.
9. Centers for Disease Control and Prevention (2001b) HIV prevalence trends in selected populations in the United States. Results from national serosurveillance, 1993-1997. http://www.cdc. gov/hiv/pubs/hivprevalence/ hivprevalence.htm.
10. Cortina-Borja M, Cliffe S, Tookey P, Williams D, Cubitt WD & Peckham C (2004) HIV prevalence in pregnant women in an ethnically diverse population in the UK: 1998-2002. AIDS 18, 535-540.
11. Curtin PD (1969) The Atlantic Slave Trade. A Census. University of Wisconsin Press, Madison, WI.
12. Dean M, Carrington M, Winkler C et al. (1996) Genetic restriction of HIV-1 infection and progression to AIDS by a deletion allele of the CKR5 structural gene. Science 273, 1856-1862.
13. Downs AM & De Vincenzi I for the European Study Group in Heterosexual Transmission of HIV (1996) Journal of Acquired Immune Deficiency Syndromes 11, 388-395.
14. Eltis D, Behrendt SD, Richardson D & Klein HS (1999) The Trans-atlantic Slave Trade. A Database on CD-Rom. Cambridge University Press, Cambridge.
15. Ferry B, Caraël M, Buvé A et al. (2001) Comparison of key parameters of sexual behaviour in four African urban populations with different levels of HIV infection. AIDS 15 (Suppl. 4), S41-S50.
16. Field MG (2004) HIV and AIDS in the former Soviet bloc. New England Journal of Medicine 351, 117-120.
17. Flannery B, Schrag S, Bennett NM et al. (2004) Impact of childhood vaccination on racial disparities in invasive Streptococcus pneumoniae infections. Journal of the American Medical Association 291, 2197-2203.
18. Fowke KR, Nagelkerke NJ, Kimani J et al. (1996) Resistance to HIV-1 infection among persistently seronegative prostitutes in Nairobi, Kenya. Lancet 348, 1347-1351.
19. Fowke KR, Dong T, Rowland-Jones SL et al. (1998) HIV type 1 resistance in Kenyan sex workers is not associated with altered cellular susceptibility to HIV type 1 infection or enhanced beta-chemokine production. AIDS Research and Human Retroviruses 14, 1521-1530.
20. Garcia Abreu A, Noguer I & Cowgill K (2003) HIV/AIDS in Latin American Countries. The Challenges Ahead. The World Bank, Washington, DC.
21. Garfein RS, Doherty MC, Monterroso ER et al. (1998) Prevalence and incidence of hepatitis C virus infection among young adult injection drug users. Journal of Acquired Immune Deficiency Syndromes 18 (Suppl. 1), S11-S19.
22. Gonzalez AM, Brehm A, Perez JA et al. (2003) Mitochondrial DNA affinities at the Atlantic fringe of Europe. Americal Journal of Physical Anthropology 120, 391-404.
23. Gonzalez Burchard E, Ziv E, Coyle N et al. (2003) The importance of race and ethnic background in biomedical research and clinical practice. New England Journal of Medicine 348, 1170-1175.
24. Gonzalez E, Kulkarni H, Bolivar et al. (2005) The influence of CCL3L1 gene-containing segmental duplications on HIV-1/ AIDS susceptibility. Science 307, 1434-1440.
25. Gray R, Wawer M, Brookmeyer R et al. (2001) Probability of HIV-1 transmission per coital act in monogamous, heterosexual, HIV-1 discordant couples in Rakai, Uganda. Lancet 357, 1149-1153.
26. Halperin DT & Post GL (2004) Global HIV prevalence: the good news might be even better. Lancet 364, 1035-1036.
27. Harawa NT, Greenland S, Bingham TA et al. (2004) Associations of race/ethnicity with HIV prevalence and HIV-related behaviors among young men who have sex with men in 7 urban centers in the United States. Journal of Acquired Immune Deficiency Syndromes 35, 526-536.
28. Higman BW (1995) Slave Populations of the British Caribbean 1807-1834. The Press University of West Indies, Kingston.
29. Howell C, Jeffers L & Hoofnagle J (2000) Hepatitis C in African Americans: summary of a workshop. Gastroenterology 119, 1385-1396.
30. Huang Y, Paxton WA, Wolinsky SM et al. (1996) The role of a mutant CCR5 allele in HIV-1 transmission and disease progression. Nature Medicine 2, 1240-1243.
31. John AM (1988) The Plantation Slaves of Trinidad 1783-1816. A Mathematical and Demographic Enquiry. Cambridge University Press, Cambridge.
32. Karafet TM, Zegura SL, Pokush O et al. (1999) Ancestral Asian source(s) of New World Y-chromosome founder haplotypes. American Journal of Human Genetics 64, 817-831.
33. Karon J, Fleming PL, Steketee RW et al. (2001) HIV in the United States at the turn of the century: an epidemic in transition. American Journal of Public Health 91, 1060-1068.
34. Kaul R, Rowland-Jones SL, Kimani J et al. (2001) Late seroconversion in HIV-resistant Nairobi prostitutes despite pre-existing HIV-specific CD8+ responses. Journal of Clinical Investigation 107, 341-349.
35. Kelen GD, Green GB, Purcell RH et al. (1992) Hepatitis B and hepatitis C in emergency department patients. New England Journal of Medicine 326, 1399-1404.
36. Kiepiela P, Leslie AJ, Honeyborne I et al. (2004) Dominant influence of HLA-B in mediating the potential co-evolution of HIV and HLA. Nature 432, 769-774.
37. Klein HS (1999) The Atlantic Slave Trade. Cambridge University Press, Cambridge.
38. Lell JT, Sukernik RI, Starikovskaya YB et al. (2002) The dual origin and Siberian affinities of native American Y chromosomes. American Journal of Human Genetics 70, 192-206.
39. MacDonald KS, Fowke K, Kimani J et al. (2000) Influence of HLA supertypes on susceptibility and resistance to human immunodeficiency virus type 1 infection. Journal of Infectious Diseases 181, 1581-1589.
40. Martinson JJ, Chapman NH, Rees DC et al. (1997) Global distribution of the CCR5 gene 32-basepair deletion. Nature Genetics 16, 100-103.
41. Merriwether DA, Hall WW, Vahlne A et al. (1996) mtDNA variation indicates Mongolia may have been the source for the founding population for the new world. American Journal of Human Genetics 59, 204-212.
42. Miller WC, Ford CA, Morris M et al. (2004) Prevalence of chlamydial and gonococcal infections among young adults in the United States. Journal of the American Medical Association 291, 2229-2236.
43. Miller WC, Ford CA, Morris M et al. (2003) Prevalence of Trichomoniasis in the US: Results from a Representative National Sample of young Adults. Abstract 0527, July 2003, 15th Biennial Congress of the International Society for Sexually Transmitted Diseases Research, Ottawa, Canada.
44. Muir AJ, Bornstein JD & Killenberg PG and Atlantic Coast Hepatitis Treatment Group (2004) Peginterferon alfa-2b and ribavirin for the treatment of chronic hepatitis C in blacks and non-Hispanic whites. New England Journal of Medicine 350, 2265-2271.
45. Mummidi S, Ahuja SS, Gonzalez E et al. (1998) Genealogy of the CCR5 locus and chemokine system gene variants associated with altered rates of HIV-1 disease progression. Nature Medicine 4, 786-793.
46. Nuorti JP, Butler JC, Farley M et al. (2000) Cigarette smoking and invasive pneumococcal disease. New England Journal of Medicine 342, 681-689.
47. Pereira L, Prata MJ & Amorim A (2000) Diversity of mtDNA lineages in Portugal: not a genetic edge of European variation. Annals of Human Genetics 64, 491-506.
48. Philpott S, Weiser B, Tarwater P et al. (2003) CC Chemokine Receptor 5 genotype and susceptibility to transmission of HIV-1 in women. Journal of Infectious Diseases 187, 569-575.
49. Ramaley PA, French N, Kaleebu P et al. (2002) Chemokine-receptor genes and AIDS risk. Nature 417, 140.
50. Rowland-Jones SL, Dong T, Dorrell L et al. (1999) Broadly cross-reactive HIV-specific cytotoxic T-lymphocytes in highly-exposed persistently seronegative donors. Immunology Letters 66, 9-14.
51. Royce RA, Sena A, Cates W et al. (1997) Current concepts: sexual transmission of HIV. New England Journal of Medicine 336, 1072-1078.
52. Ruwende C, Khoo SC, Snow RW et al. (1995) Natural selection of hemi-and heterozygotes for G6PD deficiency in Africa by resistance to severe malaria. Nature 376, 246-249.
53. Samson M, Libert F, Doranz BJ et al. (1996) Resistance to HIV-1 infection in Caucasian individuals bearing mutant alleles of the CCR-5 chemokine receptor gene. Nature 382, 722-725.
54. Scheper-Hughes N (1993) AIDS, public health, and human rights in Cuba. Lancet 342, 965-967.
55. Schliekelman P, Garner C & Slatkin M (2001) Natural selection and resistance to HIV. Nature 411, 545-546.
56. Smith DK, Gwinn M, Selik RM et al. (2000) HIV/AIDS among African Americans: progress or progression? AIDS 14, 1237-1248.
57. Smith MW, Dean M, Carrington M et al. (1997) Contrasting genetic influence of CCR2 and CCR5 variants on HIV-1 infection and disease progression. Science 277, 959-965.
58. Stead WW, Senner JW, Reddick WT et al. (1990) Racial differences in susceptibility to infection by Mycobacterium tuberculosis. New England Journal of Medicine 322, 422-427.
59. Stoneburner RL & Low-Beer D (2004) Population-level HIV declines and behavioural risk avoidance in Uganda. Science 304, 714-718.
60. Sullivan A, Wigginton J & Kirschner D (2001) The coreceptor mutation CCR5A32 influences the dynamics of HIV epidemics and is selected for by HIV. Proceedings of the National Academy of Sciences of the United States of America 98, 10214-10219.
61. Thomas DL, Vlahov D, Solomon L et al. (1995) Correlates of hepatitis C virus infections among injection drug users. Medicine 74, 212-220.
62. Thorpe LE, Quellet LJ, Levy JR, Williams IT & Monterroso ER (2000) Hepatitis C virus infection: prevalence, risk factors, and prevention opportunities among young injection drug users in Chicago, 1997-1999. Journal of Infectious Diseases 182, 1588-1594.
63. UNAIDS (2002) Report on the Global HIV/AIDS Epidemic 2002. UNAIDS, Geneva.
64. UNAIDS (2003) AIDS Epidemic Update, December 2003. http:// www.who.int/hiv/pub/epidemiology/epi2003/en/.
65. UNAIDS (2004a) 2004 Report on the Global AIDS Epidemic. UNAIDS, Geneva.
66. UNAIDS (2004b) AIDS Epidemic Update December 2004. UNAIDS, Geneva.
67. Walker N, Stanecki KA, Brown T et al. (2003) Methods and procedures for estimating HIV/AIDS and its impact: the UNAIDS/WHO estimates for the end of 2001. AIDS 17, 2215-2225.
68. Whitney GG, Schaffner W & Butler JC (2001) Rethinking recommendations for use of pneumococcal vaccines in adults. Clinical Infectious Diseases 33, 662-675.
69. Zaznobova NA & Ivanova NV (2000) The HIV infection epidemic in the city of Irkutsk, Russia. (Russian). Zhurnal Mikrobiologii, Epidemiologii, i Immunobiologii 4, 38-39.